To evaluate the genetic damage induced by tuberculosis infection and also by a combination of therapeutic exposure to anti-tuberculosis (anti-TB) drugs (isoniazid ⍣ rifampicin ⍣ pyrazinamide ⍣ ethambutol or streptomycin) we have considered chromosome aberrations (CA) and micronuclei (MN) in binucleate peripheral blood lymphocytes from 36 patients diagnosed with pulmonary tuberculosis prior to receiving anti-TB drugs in the first phase and in the second phase after 6 months of therapy with anti-TB drugs. The same cytogenetic study has also been performed on 36 healthy individual controls. It was shown that the frequencies of both CA and micronucleated binucleate cells increased significantly after therapy with anti-TB drugs as compared with TB patients and controls. In addition, we observed that both cytogenetic markers (CA and MN) in patients before treatment with anti-TB drugs were significantly (P < 0.05) higher than controls. No relationship was found between the frequency of MN and donor age. Thus, apart from drug effects, infection with tuberculosis is associated with increased CA and MN.
Introduction
For the genotoxic effects of physical and chemical agents, formation of chromosome aberrations (CA) and sister chromatid exchanges (SCEs) are cytogenetic end points. Assessment of these cytogenetic abnormalities has been well documented. These aberrations can be formed by cytotoxins produced by many viral and some bacterial illnesses (Chatterjee and Ghosh, 1989) . Tuberculosis, as a chronic bacterial infection, is expected to induce chromosomal damage in the host by production of cytokines and active metabolites of host immune cells and also by production of microorganism exo/ endotoxins (Gopal Rao et al., 1990a . The information available on whether tuberculosis infection is per se clastogenic or not is little and contradictory (Jaju et al., 1983; Ekmekci and Sayli, 1995) .
Moreover, drugs commonly used in tuberculosis treatment may have a mutagenic effect on the human genome, as may any other foreign chemical agent. This is of greater concern in the newly employed short course regimens, which expose patients to a greater number of drugs, namely isoniazid (INH), rifampicin (RIF), ethambutol (ETB) and pyrazinamide (PZI) .
The cytogenetic effects of most of these drugs were investigated individually, either on human lymphocytes (Roman and Georgian, 1977) or on CHO (Klamerth, 1978) and rat bone marrow cells (Cirnu-Georgian and Linghel, 1971) .
Synergistic and/or antagonistic actions of these drugs in various regimen combinations have also been sought, without any convincing or uniform conclusions. While some authors found that these drugs alone or in combination are nonclastogenic (Basler, 1978; Bauchinger et al., 1978; Muller et al., 1978) , others demonstrated the synergistic interaction of anti-tuberculous (anti-TB) drugs in production of chromosomal damage (Jaju et al., 1981 (Jaju et al., , 1983 Roman et al., 1983) . These contradictions may partly reflect usage of different cytogenetic end points, such as CA, SCE and mitotic index.
Moreover, to our knowledge, no report is available on the effects of anti-TB drugs in exposed patients using the micronucleus (MN) assay. Therefore, we report the results of an MN assay for the first time in treated and untreated tuberculosis patients.
MN arise from chromosomal fragments or whole chromosomes which are not incorporated into daughter nuclei during mitosis (Countryman and Heddle, 1976; Heddle et al., 1983) . The MN assay using the cytokinesis block method was recently proposed as a fast and sensitive cytogenetic technique for evaluation of chromosomal damage in human lymphocytes (Fenech and Morley, 1985; Fenech, 1997) .
In this study we have evaluated the cytogenetic effects of tuberculosis infection and also of a short course combined anti-TB regimen (INH ϩ RIF ϩ PZI ϩ ETB) in newly diagnosed patients exposed to standard administered doses of these drugs, with regard to structural CA and the MN assay using the cytokinesis block method in human lymphocytes.
Materials and methods

Patient group
The patient group consisted of 36 newly diagnosed and untreated adult patients (17 male and 19 female with a mean age of 39 Ϯ 17 years) suffering from pulmonary tuberculosis, who were admitted to the tuberculosis ward of the National Research Institute of Tuberculosis and Lung Disease (NRITLD), Tehran.
After their disease was confirmed by bacteriological and radiological examination, all patients were interviewed to exclude recent exposure to any drug, radiation (excluding chest radiography exposure to 5-7.5 m Sv, which is negligible) or viral or bacterial infection.
Heparinized peripheral venous blood samples were taken before treatment began. Then anti-TB drugs were administered to each patient according to a standard protocol (Table I ). Patients were then followed for 6 months, after which they were re-examined.
Control group
The control group was represented by 36 healthy adult individuals residing in Tehran (17 males and 19 females with a mean age of 39 Ϯ 16 years) who denied any recent exposure to radiation, toxic and chemical agents or drugs. They matched our case group by sex and age and were preferably selected from relatives of the patient group when possible (11 individuals).
To eliminate the role of smoking, as a confounding factor, both the patients and controls were non-smokers. Lymphocyte culture Whole blood cultures were performed according to a standard method (IAEA, 1986) , with minor modifications. Aliquots of 0.3 ml whole blood from each subject were added to 5 ml culture medium consisting of Ham's F10 (Gibco BRL) supplemented with 20% fetal calf serum (FCS) (Gibco BRL), 100 U/ ml penicillin, 100 µg/ml streptomycin, 1.0% L-glutamic and 1.0% phytohemagglutinin (PHA) (Gibco BRL) for mitogenic stimulation. The cultures were incubated at 37°C for CA (48 h) and MN (72 h).
Chromosome aberrations
After incubation (45 h), colcemid (Gibco BRL) was added to the cultures at a final concentration of 0.2 µg/ml 3 h before cell harvest. The cells were treated with a hypotonic solution of 0.075 M KCl for 15 min at 37°C, then fixed with cold 1:3 acetic acid:methanol. The fixed cell suspension was dropped onto a clean glass slide, air dried and stained with 10% Giemsa solution. All slides were coded before being scored. 
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The slides were screened for number of CAs amongst metaphases under 1000ϫ magnification. On average, for each sample~170 metaphases on two slides from the same culture tube were scored for CAs, including chromatid gaps, isochromatid gaps, breaks, fragments and minutes.
Since gaps (achomatic lesions) do not yield acentric fragments as true discontinuities of the chromosome structure (Buckton and Evans, 1973) , in this study gaps were recorded and mean values of aberrant cells were evaluated excluding and including gaps.
Micronucleus assay MN were prepared in cytokinesis-blocked cells using cytochalasin B (Cyt-B) following the method suggested by Fenech and Morley (1985) . The cultures were incubated for 72 h and, 44 h after the begining of incubation, Cyt-B (Sigma) at a concentration of 3 µg/ml, diluted in saline from a stock solution in DMSO (Merck), was added to the cultures to block cytokinesis. The cells were collected by centrifugation and treated with a hypotonic solution of 0.075 M KCl for 3 min. After centrifugation at 100 g and removal of the supernatant, the cells were fixed with a freshly made mixture of methanol:acetic acid (3:1). Centrifugation and resuspension were carried out three times and the cells were then dropped onto a warm clean slide and stained with 5% Giemsa.
Analysis of micronuclei
To determine the MN yield we scored nearly 1000 BN cells where possible for each experimental condition under magnifications of 400ϫ and finally 1000ϫ from 2 slides/culture. Identification of MN was according to the criteria summarized by Countryman and Heddle (1976) : (i) only cells with a distinct cytoplasm and distinct binucleation were analyzed for the presence of MN; (ii) only MN entirely inside the cytoplasm, separated from the main nucleus and with a diameter Ͻ1/3 of the size of the main nucleus were scored; (iii) only MN staining the same as or lighter than the nucleus were scored. Routinely we scored on average~1000 binucleate cells for the presence of MN in each group (before treatment, after treatment and controls) and mean values of the results were calculated.
Statistical analysis
Statistical analyses of mean frequency of aberrations and MN in 1000 cells were performed after the final mean of each variable was calculated from the individual means of that variable using either paired or independent t-tests. Regression analyses were carried out to determine the relationship between the frequency of MN and the age of the donors. Data were analyzed using the SPSS package and P Ͻ 0.05 was considered significant. All data shown in Results are expressed as means Ϯ SD.
Results
The results of CA analysis of patients with pulmonary tuberculosis before and after treatment and of the control group are shown in Tables II and III. The observed CAs consisted mainly of chromatid gaps, isochromatid gaps, breaks (mainly of chromatid type) and fragments. Other aberrations, such as minutes, acentric rings, dicentrics and exchanges, were rarely seen.
A great percentage of aberrations in tuberculous patients 
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were gaps (Table III) . The spontaneous frequencies of CAs were 1.00 Ϯ 0.74 (including gaps) and 0.28 Ϯ 0.32 (excluding gaps) (Table II) . The frequencies of aberrations (excluding gaps) in untreated and treated patients were 0.58 Ϯ 0.59 and 1.40 Ϯ 0.95, respectively. The observed differences were significant (P Ͻ 0.0005). The frequencies of aberrations (including gaps) in untreated and treated patients were 1.72 Ϯ 1.00 and 3.79 Ϯ 1.69, respectively (Tables III-VI) , which shows a significant increase after treatment (P Ͻ 0.0005). The incidence of CAs, excluding and including gaps, in untreated tuberculosis patients were significantly higher than healthy controls (P Ͻ 0.05 and P Ͻ 0.005, respectively). Induction of CAs in patients exposed to anti-TB drugs was also significantly (P Ͻ 0.005) increased when compared with controls (Table VI) . The increase was present in a significant number of our patients (29 out of a total of 36 patients). Only a few polyploids were observed in tuberculosis patients (Table III) .
For one MN assay, the mean frequency (MN/1000 CB cells Ϯ SD) for each person was calculated and the mean of means was the data point for comparison among healthy control and tuberculosis patients before and after treatment ( Table V) . The spontaneous frequency of MN was 9.9 Ϯ 47 per 1000 cells and ranged from 3 to 19 per 1000 cells. Mean frequency of MN in unexposed tuberculosis patients was 12.30 Ϯ 4.7 per 1000 cells and was significantly increased when compared with the control group (P ϭ 0.037). MN frequency in exposed patients was 16.66 Ϯ 5.7 per 1000 cells, which was also significantly higher than the control (Table V) and untreated patient groups (P Ͻ 0.05). To investigate the relationship between the frequency of MN and age of the donors, we used least squares regression analysis. No relationship was found between the frequency of MN and donor age, either in the control (r 2 ϭ 0.02, P ϭ 0.32) or in unexposed (r 2 ϭ 0.001, P ϭ 0.8) and exposed patients (r 2 ϭ 0.04, P ϭ 0.2). Furthermore no direct correlation between MN and CAs was found, as the patients with no increase in aberrations were not the same ones as those without an increase in MN (Tables  III and V) .
Discussion
This study was performed to analyze CA and MN formation in pulmonary tuberculosis patients and controls for evaluation of the genomic effects of anti-TB drugs (INH ϩ RIF ϩ PZI ϩ ETB). The results of our study show that significant differences in CA frequency exist between exposed patients and untreated ones (Tables III and IV) . The frequency of MN was also significantly higher in the exposed compared with Since the discovery and general use of anti-TB drugs, their possible mutagenic effects, either alone or in combination, have been studied by many investigators. INH in the presence of N-methyl-N-nitrosourea depressed cell number and mitotic index in peripheral human lymphocytes and inhibited postreplication processes in CHO cells (Klamerth, 1978) .
Mutagenic effects of INH in combination with other drugs have been observed by other investigators (Jaju et al., 1981 (Jaju et al., , 1983 . Similar results were obtained in patients exposed to long term anti-TB regimens (Roman et al., 1983 ) and short term therapy (Gopal Rao et al., 1990b , which are in accord with our results. However, in a cytogenetic study (Ekmekci and Sayli, 1995) no differences in frequencies of CA and SCE were shown before and after treatment with combined anti-TB drugs, but the mitotic index was found to be decreased after exposure to the drugs.
A significantly higher number of aberrations observed among untreated tuberculous patients compared with controls was also reported by Gopal et al. (1990b) , who suggested that endo/exotoxins released by Mycobacterium tuberculosis act as chemical mutagens in generating CA in affected individuals. 
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Other similar infections caused by Mycobacterium lepra (de Souza and Thomas, 1988 ) and a number of viruses, including both A and B hepatitis (Chatterjee and Ghosh, 1989) were demonstrated to cause CAs in human lymphocytes. The spontaneous frequency of chromosome aberration per 100 cells in our control group was 0.92 Ϯ 0.13, which is comparable with those obtained in our previous study in Tehran, reporting spontaneous CAs (including gaps) as 1.13 per 100 cells (Fazeli et al., 1993) . This minor difference could be explained by variability observed in spontaneous CAs in various laboratories (Lloyd et al., 1980) . The MN assay was also considered in our study, for the first time, in both treated and untreated tuberculous patients compared with controls. MN are the products of fragmented chromosomes induced by mutagenic chemical compounds (Heddle et al., 1983) .
Although methods for CA analysis are well documented, recently in vivo and in vitro MN assays using Cyt-B on human lymphocytes have been developed extensively as a reliable, simple and quick technique for biomonitoring studies of chemical compounds to substitute for CA analysis (Fenech, 1997; Miller et al., 1997) . According to the results obtained in this study the mean frequency of MN in controls was 9.9 per 1000 CB cells and ranged from 3 to 19. Although the mean and baseline levels of MN frequency in CB cells are variable, this value is not significantly different from the results obtained by other investigators of 8.8 (French and Morley, 1985) , 8.0 (Huber et al., 1989) and 12 MN/1000 CB cells (Krishnaja and Sharma, 1994) .
The results of collaborative studies with 30 European laboratories have indicated that in recent years the concentration of Cyt-B used has tended towards 6 µg/ml but the percentage of binucleated cells at both 3 and 6 µg/ml was 50% (Surrales and Natarajan, 1997) . The concentration of 3 µg/ml originally recommended by Fenech and Morley (1985) has been reported and widely accepted in the literature (Huber et al., 1992; Krishnaja and Sharma, 1994; Thierens et al., 1996) . Therefore, in this study we have used 3 µg/ml Cyt-B. The relationship between MN frequency and age of donors has been considered by several authors, with discordant results. Some reports have described a positive correlation between age and MN frequency in human lymphocytes (Fenech and Morley, 1986; Ghosh et al., 1990; Migliore et al., 1991; Ganguly, 1993; Mill et al., 1996; Thierens et al., 1996) , while other cytogenetic studies on MN have not shown an age effect (Huber et al., 1989; Sinues et al., 1991) . In the present study no relationship was found between the frequency of MN and donor age in both controls and patients.
It is concluded that an overall and significant increase in cytogenetic markers (CAs and MN) exists in pulmonary tuberculosis patients receiving daily treatment for 6 months compared with untreated and control groups. It was also observed that tuberculosis infection, apart from drug exposure, is associated with an increase in CA and MN frequency, the mediators of which remain to be elucidated. Although the MN assay is a simple and precise method for cytogenetic studies and the results obtained with this assay show concordancy with CA results on the whole, the lack of a direct correlation between the results in individual cases with the two assays necessitates that the MN and CA assays be regarded as complementary to each other for assessment of cytogenetic aberrations.
